Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 364


IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.

Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD.

J Immunol. 2004 Jan 1;172(1):550-9.


Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.

Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, Ross DJ, Strieter RM.

J Immunol. 2002 Jul 15;169(2):1037-49.


Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.

Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, Wu-Hsieh BA, Gerard C, Luster A, Liao F.

J Immunol. 2006 Aug 1;177(3):1855-63.


IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.

Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, De Pità O, Puddu P, Girolomoni G.

J Immunol. 2000 Aug 1;165(3):1395-402.


Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.

Whiting D, Hsieh G, Yun JJ, Banerji A, Yao W, Fishbein MC, Belperio J, Strieter RM, Bonavida B, Ardehali A.

J Immunol. 2004 Jun 15;172(12):7417-24.


IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.

Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD.

J Immunol. 2002 Apr 1;168(7):3195-204.


CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis.

Morimoto J, Yoneyama H, Shimada A, Shigihara T, Yamada S, Oikawa Y, Matsushima K, Saruta T, Narumi S.

J Immunol. 2004 Dec 1;173(11):7017-24.


The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.

Means TK, Hayashi F, Smith KD, Aderem A, Luster AD.

J Immunol. 2003 May 15;170(10):5165-75.


Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.

Hildebrandt GC, Corrion LA, Olkiewicz KM, Lu B, Lowler K, Duffner UA, Moore BB, Kuziel WA, Liu C, Cooke KR.

J Immunol. 2004 Aug 1;173(3):2050-9.


CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.

Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S, Hansen JB, Dissing S, Malling HJ, Skov PS, Poulsen LK.

J Immunol. 2000 Aug 1;165(3):1548-56.


Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.

Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, Murphy M, Liao F, Farber J, Cassatella MA.

J Immunol. 1999 Apr 15;162(8):4928-37.


The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo.

Park MK, Amichay D, Love P, Wick E, Liao F, Grinberg A, Rabin RL, Zhang HH, Gebeyehu S, Wright TM, Iwasaki A, Weng Y, DeMartino JA, Elkins KL, Farber JM.

J Immunol. 2002 Aug 1;169(3):1433-43.


CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).

Sauty A, Colvin RA, Wagner L, Rochat S, Spertini F, Luster AD.

J Immunol. 2001 Dec 15;167(12):7084-93.


The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.

Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD.

J Immunol. 1999 Mar 15;162(6):3549-58.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk